INTUITIVE SURGICAL INC (ISRG)
US46120E6023 - Common Stock
Taking everything into account, ISRG scores 6 out of 10 in our fundamental rating. ISRG was compared to 196 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ISRG a very profitable company, without any liquidiy or solvency issues. ISRG is growing strongly while it is still valued neutral. This is a good combination! With these ratings, ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
ISRG had a positive operating cash flow in the past year.
Each year in the past 5 years ISRG has been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
1.2 Ratios
ISRG has a Return On Assets of 11.64%. This is amongst the best in the industry. ISRG outperforms 94.90% of its industry peers.
ISRG has a better Return On Equity (13.51%) than 89.80% of its industry peers.
With an excellent Return On Invested Capital value of 11.40%, ISRG belongs to the best of the industry, outperforming 93.37% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 8.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.64% | ||
| ROE | 13.51% | ||
| ROIC | 11.4% |
ROA(3y)11.47%
ROA(5y)11.62%
ROE(3y)13.27%
ROE(5y)13.48%
ROIC(3y)12.21%
ROIC(5y)11.96%
1.3 Margins
ISRG has a Profit Margin of 25.24%. This is amongst the best in the industry. ISRG outperforms 97.45% of its industry peers.
In the last couple of years the Profit Margin of ISRG has declined.
With an excellent Operating Margin value of 24.99%, ISRG belongs to the best of the industry, outperforming 95.92% of the companies in the same industry.
In the last couple of years the Operating Margin of ISRG has declined.
ISRG has a Gross Margin of 66.39%. This is in the better half of the industry: ISRG outperforms 72.45% of its industry peers.
ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.99% | ||
| PM (TTM) | 25.24% | ||
| GM | 66.39% |
OM growth 3Y0.73%
OM growth 5Y-5.65%
PM growth 3Y1.22%
PM growth 5Y-3.58%
GM growth 3Y0.37%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
Compared to 1 year ago, ISRG has more shares outstanding
ISRG has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 38.89 indicates that ISRG is not in any danger for bankruptcy at the moment.
ISRG has a better Altman-Z score (38.89) than 98.47% of its industry peers.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 38.89 |
ROIC/WACC1.15
WACC9.87%
2.3 Liquidity
A Current Ratio of 4.76 indicates that ISRG has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.76, ISRG is doing good in the industry, outperforming 66.84% of the companies in the same industry.
A Quick Ratio of 4.02 indicates that ISRG has no problem at all paying its short term obligations.
ISRG has a better Quick ratio (4.02) than 70.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.76 | ||
| Quick Ratio | 4.02 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.75%, which is quite impressive.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.97% yearly.
ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.49%.
Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.85% on average per year.
EPS 1Y (TTM)21.75%
EPS 3Y19.06%
EPS 5Y8.97%
EPS growth Q2Q30.08%
Revenue 1Y (TTM)14.49%
Revenue growth 3Y17.8%
Revenue growth 5Y13.85%
Revenue growth Q2Q16.51%
3.2 Future
ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.19% yearly.
The Revenue is expected to grow by 12.33% on average over the next years. This is quite good.
EPS Next Y11.63%
EPS Next 2Y14.35%
EPS Next 3Y15.53%
EPS Next 5Y15.19%
Revenue Next Year13.01%
Revenue Next 2Y14.19%
Revenue Next 3Y14.68%
Revenue Next 5Y12.33%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 65.26, the valuation of ISRG can be described as expensive.
70.41% of the companies in the same industry are more expensive than ISRG, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.80. ISRG is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 58.46, the valuation of ISRG can be described as expensive.
72.96% of the companies in the same industry are more expensive than ISRG, based on the Price/Forward Earnings ratio.
ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.26 | ||
| Fwd PE | 58.46 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than the industry average as 69.90% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 70.92% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 176.2 | ||
| EV/EBITDA | 55.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 15.53% in the coming years.
PEG (NY)5.61
PEG (5Y)7.28
EPS Next 2Y14.35%
EPS Next 3Y15.53%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INTUITIVE SURGICAL INC
NASDAQ:ISRG (4/18/2024, 7:01:48 PM)
Premarket: 383 +10.37 (+2.78%)372.63
-1.54 (-0.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap132.08B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.26 | ||
| Fwd PE | 58.46 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.61
PEG (5Y)7.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.64% | ||
| ROE | 13.51% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 24.99% | ||
| PM (TTM) | 25.24% | ||
| GM | 66.39% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.76 | ||
| Quick Ratio | 4.02 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)21.75%
EPS 3Y19.06%
EPS 5Y
EPS growth Q2Q
EPS Next Y11.63%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.49%
Revenue growth 3Y17.8%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y